Skip to content

Taysha Gene Therapies, Inc. TSHA Capital investments accrued but not yet paid

Capital investments accrued but not yet paid at other companies

FMC Corporation logo
FMC CorporationFMC
$1.9M-80.4%
Vestis logo
VestisVSTS
$4.2M
HTF
Heartflow, Inc. Common StockHTFL
$912K+15,100%
Taboola.com Ltd. logo
Taboola.com Ltd.TBLA
$617K-67.4%
Playtika Holding Corp. logo
Playtika Holding Corp.PLTK
$4M+66.7%
ESN
Essent GroupESNT
$85K

Other financials

Income statement

See full
Revenue--100%
Operating income-$43.5M-103%
Net income-$42.4M-97.0%
EPS (diluted)-$0.12-50.0%

Balance sheet

See full
Cash & equivalents$276.6M+137%
Total debt$68.6M+11.2%
Total equity$211.9M+285%
Total assets$300.4M+117%

Cash flow

See full
Operating cash flow-$40.9M-85.6%
CapEx$24.0K-93.7%
Free cash flow-$40.9M-82.6%

Valuation

See full
Market cap$1.99B+351%

Profitability

See full
Operating margin-1,774.4%+1,437pp
Net margin-1,738.4%+1,407pp
FCF margin-1,503.6%+621pp

Returns & leverage

See full
Return on equity-97.3%-27.3pp
Debt / equity0.3×-0.8×
Current ratio14×+8.7×

Where this comes from

Reported directly by Taysha Gene Therapies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.

The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed August 12, 2025, on SEC EDGAR. View the filing →

Ask your AI about Taysha Gene Therapies, Inc.'s capital investments accrued but not yet paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Taysha Gene Therapies, Inc.'s capital investments accrued but not yet paid?
Taysha Gene Therapies, Inc. (TSHA) reported capital investments accrued but not yet paid of $388K in Q2 2025.
How has Taysha Gene Therapies, Inc.'s capital investments accrued but not yet paid changed year-over-year?
Taysha Gene Therapies, Inc.'s capital investments accrued but not yet paid increased by 3273.9% year-over-year, from $11.5K to $388K.